Wikidata

(Q113915455)

English

Research Study to Investigate How Well Semaglutide Works in People Living With Heart Failure and Obesity

clinical trial

In more languages

Statements

short name
STEP-HFpEF (English)
0 references
title
Effect of Semaglutide 2.4 mg Once Weekly on Function and Symptoms in Subjects With Obesity-related Heart Failure With Preserved Ejection Fraction (English)
0 references
medical condition
heart failure
0 references
overweight
0 references
country
Argentina
0 references
Australia
0 references
Canada
0 references
Denmark
0 references
Germany
0 references
Hungary
0 references
Israel
0 references
Netherlands
0 references
Poland
0 references
Spain
0 references
United Kingdom
0 references
start time
16 March 2021
0 references
end time
15 March 2023
0 references
number of participants
516
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q113915455&oldid=2149034259"